We then performed similar BGLF2-FLAG IPs (with RNase A treatment) in AGS gastric carcinoma cells, commonly used to study EBV lytic infection, and again confirmed recovery of Ago2 and TNRC6A (Fig 1B). This evidence concerns the gene RNASE1 and gastric carcinoma.